4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-384042
Chief Executive Officer sold 19,023 shares at $37.94 ($721,733)
- Chief Executive Officer acquired 40,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Barrow Robert · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-02 | Grant or award : show line 1 in the form 10b5-1 | +40,000 | 1,513,663 | D | ||
| 2026-09-03 | Sale : show line 2 in the form 10b5-1 | −19,023 | $37.94 | $721,733 | 1,494,640 | D |
| Open-market sales · 19,023 sh · avg $37.94 · $721,733 | ||||||
Loading xslF345X06/ownership.xml…